NYSE:NNVC
NanoViricides, Inc Stock News
$1.10
-0.0100 (-0.90%)
At Close: Apr 26, 2024
Insights into the Global Coronavirus Vaccine Market to 2027 - Drivers, Restraints, Opportunities and Threats - ResearchAndMarkets.com
12:00am, Thursday, 25'th Jun 2020
The
SHELTON, CT / ACCESSWIRE / June 23, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedi
Short Interest in NanoViricides Inc (NYSEAMERICAN:NNVC) Decreases By 30.8%
02:02am, Friday, 19'th Jun 2020
NanoViricides Inc (NYSEAMERICAN:NNVC) was the recipient of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totalling 303,800 shares, a decr
NanoViricides (NYSEAMERICAN:NNVC) Trading Up 0.7%
07:02am, Wednesday, 17'th Jun 2020
NanoViricides Inc (NYSEAMERICAN:NNVC)’s share price was up 0.7% during mid-day trading on Monday . The company traded as high as $6.94 and last traded at $6.94, approximately 4,417 shares were trade
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 8) * Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN)
NanoViricides Signs Memorandum of Understanding for Human Coronavirus Drug Development License
10:17am, Tuesday, 09'th Jun 2020NanoViricides Signs Memorandum of Understanding for Human Coronavirus Drug Development License
10:15am, Tuesday, 09'th Jun 2020
SHELTON, CT / ACCESSWIRE / June 9, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines pl
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 8)
Biohaven Pharmaceutical...
Global Coronavirus Vaccine Market: Trends, Forecast & Opportunities (2019-2025) - ResearchAndMarkets.com
12:00am, Wednesday, 03'rd Jun 2020
The
The
SHELTON, CT / ACCESSWIRE / May 26, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines p